US Patent 8008073 Anti-Mpl antibodies
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+462 characters)
Article
Patent abstract
Anti-human Mpl antibodies were isolated and purified. Anti-human Mpl diabodies and anti-human Mpl sc(Fv)2 were prepared using genetic engineering techniques and anti-human Mpl sc(Fv)2 was also humanized. The diabodies and sc(Fv)2 were assayed for TPO-like agonistic activity, and were found to have activities higher than those of anti-human Mpl antibodies, or activities equivalent to or higher than those of naturally-occurring human TPO ligand.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008073 Anti-Mpl antibodies US Patent 8008073 Anti-Mpl antibodies
Infobox
Patent Number
0800807300
Patent Number
800807300
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080080730
Date of Patent
August 30, 2011
0Patent Application Number
128748720
Date Filed
September 2, 2010
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080080730
Date of Patent
August 30, 2011
0Patent Application Number
128748720
Date Filed
September 2, 2010
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08008073 Anti-Mpl antibodies
Infobox
Is a
Patent jurisdiction
Patent number
08008073
Date of patent
August 30, 2011
Patent application number
12874872
Date Filed
September 2, 2010
Patent primary examiner
Find more entities like US Patent 8008073 Anti-Mpl antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
